Analysis of IgG4 class switch-related molecules in IgG4-related disease.
Analysis of IgG4 class switch-related molecules in IgG4-related disease.
复制标题
DOI:
10.1186/ar3924
复制
发表时间:
2012-07-23
影响因子:
4.9
通讯作者:
Sumida T
中科院分区:
文献类型:
--
作者:
Tsuboi H;Matsuo N;Iizuka M;Tsuzuki S;Kondo Y;Tanaka A;Moriyama M;Matsumoto I;Nakamura S;Sumida T
Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a new disease entity characterized by high serum IgG4 levels, IgG4-positive plasmacytic infiltration, and fibrosis in various organs. The purpose of this study was to determine the mechanism of upregulation of IgG4 class switch recombination in IgG4-RD. We extracted RNA from peripheral blood mononuclear cells (PBMCs) of patients with IgG4-RD (n = 6), Sjögren syndrome (SS) (n = 6), and healthy controls (n = 8), from CD3-positive T cells and CD20-positive B cells sorted from PBMCs of patients with IgG4-RD (n = 3), SS (n = 4), and healthy controls (n = 4), as well as from labial salivary glands (LSGs) of patients with IgG4-RD (n = 11), SS (n = 13), and healthy controls (n = 3). The mRNA expression levels of IgG4-specific class switch-related molecules, such as Th2 cytokines (IL-4 and IL-13), Treg cytokines (IL-10 and TGF-β), and transcriptional factors (GATA3 and Foxp3) were examined with quantitative polymerase chain reaction (PCR). IgG4-nonspecific class switch-related molecules, such as CD40, CD154, BAFF, APRIL, IRF4, and AID, were also examined. The expression levels of Treg cytokines (IL-10 and TGF-β) and AID were significantly higher in LSGs of IgG4-RD than in SS and the controls (P < 0.05, each). In contrast, those of CD40 and CD154 were significantly lower in PBMCs of IgG4-RD than in SS (P < 0.05, each), whereas CD40 in CD20-positive B cells and CD154 in CD3-positive T cells were comparable in the three groups. Overexpression of IL-10, TGF-β, and AID in LSGs might play important roles in the pathogenesis of IgG4-RD, such as IgG4-specific class-switch recombination and fibrosis. IgG4 class-switch recombination seems to be mainly upregulated in affected organs.
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-08-1845
发表时间:
2009-05-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Shaffer AL;Emre NC;Romesser PB;Staudt LM
通讯作者:
Staudt LM
影响因子:
2.2
作者:
Umehara, Hisanori;Okazaki, Kazuichi;Masaki, Yasufumi;Kawano, Mitsuhiro;Yamamoto, Motohisa;Saeki, Takako;Matsui, Shoko;Sumida, Takayuki;Mimori, Tsuneyo;Tanaka, Yoshiya;Tsubota, Kazuo;Yoshino, Tadashi;Kawa, Shigeyuki;Suzuki, Ritsuro;Takegami, Tsutomu;Tomosugi, Naohisa;Kurose, Nozomu;Ishigaki, Yasuhito;Azumi, Atsushi;Kojima, Masaru;Nakamura, Shigeo;Inoue, Dai
通讯作者:
Inoue, Dai
DOI:
10.3109/08977194.2011.595714
发表时间:
2011-10
期刊:
Growth factors (Chur, Switzerland)
影响因子:
--
作者:
Biernacka A;Dobaczewski M;Frangogiannis NG
通讯作者:
Frangogiannis NG
影响因子:
2.9
作者:
Miyoshi, Hideaki;Uchida, Kazushige;Okazaki, Kazuichi
通讯作者:
Okazaki, Kazuichi
影响因子:
2.2
作者:
Miyake, Katsuhisa;Moriyama, Masafumi;Nakamura, Seiji
通讯作者:
Nakamura, Seiji